Yeast Genetic Approach to Enhance the Immunogenicity of HIV Envelope Glycoprotein

酵母遗传学方法增强 HIV 包膜糖蛋白的免疫原性

基本信息

  • 批准号:
    8500194
  • 负责人:
  • 金额:
    $ 36.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Development of a vaccine that is effective against the worldwide HIV pandemic has, to date, been unsuccessful. However, the ultimate feasibility of a useful vaccine is indicated by the fact that some individuals infected with HIV develop broadly neutralizing antibodies against the HIV viral envelope glycoprotein (Env) that provide protection against HIV infection in experimental systems. The current application describes a proposal to use random mutagenesis and screening approaches to provide better understanding of the antigenic properties of the envelope glycoprotein and to develop forms of Env with improved immunogenic properties. Based on the idea that poor affinity of Env for germline precursors to neutralizing antibodies is a major limitation on the ability of different forms of Env to elicit protective immune responses, a major goal of the project is the identification of variant forms of Env with the elevated affinity for binding such precursors. To facilitate mutagenesis and screening, the gp140 external segment of Env will be expressed at the surface of the baker's yeast Saccharomyces cerevisiae. This system was chosen based on the advantages of this yeast as a eukaryotic host for expression of heterologous proteins, because of the demonstrated usefulness of yeast for vaccine production, and because of the tools available for large-scale random mutagenesis and screening of surface-displayed proteins in yeast. The initial aim of the project is to optimize gp140 expression constructs to achieve useful levels of expression of protein exhibiting authentic antibody and receptor-binding capability at the yeast cell surface. Once these parameters are established, an initial round of mutagenesis and screening will be used for detailed mapping of the sequence determinants of epitopes for selected neutralizing antibodies, using Fluorescence Activated Cell Sorting (FACS) to identify Env variants with reduced affinity for the antibodies. In addition, the ability of yeast-expressed Env to bind to germline precursors to broadly neutralizing antibodies will be evaluated. In cases where such affinity is low (expected to be the majority of cases), libraries of randomly altered forms of Env will be screened by FACS to identify forms of the glycoprotein exhibiting enhanced affinity for the germline antibodies. If necessary to achieve an initial improvement in affinity, either single examples or libraries of partially matured forms of the neutralizing antibodies will e used for screening, followed by further iterations of screening to obtain Env variants exhibiting elevated affinities for actual germline antibodies. Candidate forms of Env exhibiting enhanced affinity for germline antibodies will be used to immunize rabbits. The resulting sera will be evaluated for their binding specificities and tested for the ability to neutralize diverse strains f HIV in an in vitro system. Overall, the proposal uses a new technology and approach for enhancing the immunogenicity of HIV Env that provides a complementary alternative to current structure-based design.
描述(由申请人提供):迄今为止,研制一种有效预防全球艾滋病毒大流行的疫苗尚未成功。然而,一种有用的疫苗的最终可行性表明,在实验系统中,一些感染HIV的个体产生针对HIV病毒包膜糖蛋白(Env)的广泛中和抗体,提供对HIV感染的保护。目前的申请描述了使用随机诱变和筛选方法来更好地了解包膜糖蛋白的抗原特性并开发具有改进免疫原性的Env形式的建议。鉴于Env对种系前体对中和抗体的亲和力较差是不同形式的Env引发保护性免疫反应能力的主要限制,该项目的一个主要目标是鉴定对这些前体具有较高亲和力的Env变体形式。为了便于诱变和筛选,将在面包酵母Saccharomyces cerevisiae表面表达Env的gp140外部片段。该系统的选择是基于酵母作为表达异种蛋白的真核宿主的优势,因为酵母在疫苗生产中的有用性,以及酵母中大规模随机诱变和表面显示蛋白筛选的工具。该项目的最初目标是优化gp140表达结构,以达到在酵母细胞表面显示真实抗体和受体结合能力的有用蛋白表达水平。一旦这些参数确定,第一轮诱变和筛选将用于选定中和抗体的表位序列决定因子的详细定位,使用荧光活化细胞分选(FACS)识别对抗体亲和力降低的Env变体。此外,酵母表达的Env与种系前体结合以广泛中和抗体的能力将被评估。在这种亲和力较低的情况下(预计是大多数情况),将通过FACS筛选随机改变形式的Env文库,以确定对种系抗体具有增强亲和力的糖蛋白形式。如果有必要实现亲和力的初步改善,将使用部分成熟形式的中和抗体的单个例子或文库进行筛选,然后进行进一步的筛选,以获得对实际种系抗体具有更高亲和力的Env变体。对种系抗体具有增强亲和力的候选Env将用于兔免疫。所得到的血清将被评估其结合特异性,并在体外系统中测试其中和多种HIV毒株的能力。总的来说,该提案使用了一种新的技术和方法来增强HIV Env的免疫原性,为当前基于结构的设计提供了一种补充选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK E. DUMONT其他文献

MARK E. DUMONT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK E. DUMONT', 18)}}的其他基金

Mechanisms of G Protein Coupled Receptor Signaling in the Yeast Pheromone Pathway
酵母信息素途径中 G 蛋白偶联受体信号传导机制
  • 批准号:
    9045646
  • 财政年份:
    2015
  • 资助金额:
    $ 36.31万
  • 项目类别:
Mechanisms of G Protein Coupled Receptor Signaling in the Yeast Pheromone Pathway
酵母信息素途径中 G 蛋白偶联受体信号传导机制
  • 批准号:
    8908573
  • 财政年份:
    2015
  • 资助金额:
    $ 36.31万
  • 项目类别:
Yeast Genetic Approach to Enhance the Immunogenicity of HIV Envelope Glycoprotein
酵母遗传学方法增强 HIV 包膜糖蛋白的免疫原性
  • 批准号:
    8410185
  • 财政年份:
    2012
  • 资助金额:
    $ 36.31万
  • 项目类别:
Yeast Genetic Approach to Enhance the Immunogenicity of HIV Envelope Glycoprotein
酵母遗传学方法增强 HIV 包膜糖蛋白的免疫原性
  • 批准号:
    8860108
  • 财政年份:
    2012
  • 资助金额:
    $ 36.31万
  • 项目类别:
Yeast Genetic Approach to Enhance the Immunogenicity of HIV Envelope Glycoprotein
酵母遗传学方法增强 HIV 包膜糖蛋白的免疫原性
  • 批准号:
    8681356
  • 财政年份:
    2012
  • 资助金额:
    $ 36.31万
  • 项目类别:
OLIGOMERIZATION STATE DETERGENT-ASSOCIATED BORON TRANSPORT MEMBRANE PROT BOR1P
低聚态洗涤剂相关硼传输膜 PROT BOR1P
  • 批准号:
    8363558
  • 财政年份:
    2011
  • 资助金额:
    $ 36.31万
  • 项目类别:
Multi-level optimization of membrane proteins for crystallography
用于晶体学的膜蛋白的多级优化
  • 批准号:
    8152514
  • 财政年份:
    2010
  • 资助金额:
    $ 36.31万
  • 项目类别:
Multi-Level Optimization of Membrane Proteins for Crystallography
用于晶体学的膜蛋白的多级优化
  • 批准号:
    8307881
  • 财政年份:
    2010
  • 资助金额:
    $ 36.31万
  • 项目类别:
Multi-Level Optimization of Membrane Proteins for Crystallography
用于晶体学的膜蛋白的多级优化
  • 批准号:
    8715826
  • 财政年份:
    2010
  • 资助金额:
    $ 36.31万
  • 项目类别:
Multi-Level Optimization of Membrane Proteins for Crystallography
用于晶体学的膜蛋白的多级优化
  • 批准号:
    8152227
  • 财政年份:
    2010
  • 资助金额:
    $ 36.31万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 36.31万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了